arrow
B

Brenda E. Porter

Stanford University
H指数:41
被引数:4,384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neurodevelopmental Outcomes from the PREVeNT Trial

PREVeNT试验的神经发育结局

2025-09-160
PRE
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial

结节性硬化症中的耐药性癫痫与TSC2基因型相关: 使用Vigatrin预防癫痫 (PREVeNT) 试验的更多发现

2024-10-011
PRE
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial
2023-09-2529
OAAI
Neurodevelopmental and Epilepsy Phenotypes in Individuals With Missense Variants in the Voltage-Sensing and Pore Domains of KCNH5
2023-02-0710
OA
Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene
2023-01-3119
OA
Somatic variants in diverse genes leads to a spectrum of focal cortical malformations

不同基因的体细胞变异导致一系列局灶性皮质畸形

BRAIN
IF11.7
2022-04-2042
OA
Real-World Preliminary Experience With Responsive Neurostimulation in Pediatric Epilepsy: A Multicenter Retrospective Observational Study
2021-12-0134
OA
Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex

结节性硬化症早期癫痫手术对神经发育影响的初步研究

2020-08-0130
OAAI
Pathogenic Variants in CEP85L Cause Sporadic and Familial Posterior Predominant Lissencephaly
NEURON
IF15
2020-04-0121
OAAI